Taros will exhibit at Nordic Life Science Days (NLSDays) 2026, taking place on
8–9 September 2026 at Kistamässan in Stockholm, Sweden.
Meet us at the German Pavilion, Booth C07.04, and discover how Taros supports pharmaceutical and biotechnology companies with chemistry-led integrated drug discovery, medicinal chemistry, hit-to-lead and lead optimisation programmes.
Taros Discovery supports small-molecule drug discovery programmes from hit identification through hit-to-lead, lead optimisation and candidate selection.
Our chemistry-led drug discovery platform brings together complementary capabilities including:
For programmes requiring additional biology, ADME, DMPK, structural biology, toxicology or other specialist capabilities, Taros coordinates established partner expertise around the chemistry programme.
Early hit identification is only the beginning of a successful drug discovery programme.
Taros works closely with Serengen GmbH to connect innovative DNA-Encoded Library technology with downstream medicinal chemistry and lead optimisation.
Serengen synthesises and screens DNA-Encoded Libraries tailored to individual drug discovery projects, providing an efficient route to high-quality starting points for further optimisation.
Promising DEL-derived hits can subsequently progress into Taros programmes for:
This connected approach allows clients to move from DEL-enabled hit discovery into broader drug discovery support when required, while retaining the flexibility to engage the capabilities most relevant to their programme.
NLSDays provides an opportunity to discuss your discovery programme directly with our team and explore where Taros can contribute scientific expertise and additional chemistry capacity.
Talk to us if you are looking for support with:
Whether you require support for a specific stage of your programme or a more integrated drug discovery collaboration, we would be pleased to discuss your project.
Event: Nordic Life Science Days 2026
Date: 8–9 September 2026
Location: Stockholm, Sweden
Taros Booth: C07.04
Exhibition: German Pavilion
The official German Pavilion exhibitor directory confirms Taros Chemicals GmbH & Co. KG at Booth C07.04.
Planning to attend NLSDays? Contact our team to arrange a meeting in Stockholm and discuss how Taros can support your drug discovery programme.
Taros Discovery supports small-molecule drug discovery from hit identification through hit-to-lead, lead optimisation and candidate selection. Its chemistry-led capabilities include medicinal and synthetic chemistry, computational chemistry, DEL-enabled hit identification, parallel chemistry and compound-library production, supported by specialist partners where programmes require complementary biology, ADME, DMPK or development capabilities.
Taros works with Serengen to incorporate DNA-Encoded Library screening into its wider drug discovery offering. Serengen’s DEL platform provides project-tailored hit identification, after which selected starting points can progress into Taros hit validation, medicinal chemistry, hit-to-lead and lead optimisation programmes.
Can Taros support a programme from hit identification to lead optimisation?
Yes. Taros can support projects across hit identification, hit validation, medicinal chemistry, hit-to-lead and lead optimisation, with additional specialist capabilities coordinated through its partner network when required.
Taros Chemicals is a contract research and custom synthesis company based in Dortmund, Germany. The company specializes in complex molecule synthesis, medicinal chemistry and chemical innovation, supporting partners in the pharmaceutical, biotechnology and specialty chemicals industries. With more than 25 years of experience, Taros provides tailored chemical solutions from early discovery to scalable synthesis, including applications in cosmetic ingredient development. Get in touch with us!
Nordic Life Science Days 2026 : Taros Chemicals at the German Pavilion Taros will exhibit at Nordic Life Science Days (NLSDays) 2026, taking place on 8–9 September 2026 at Kistamässan
Chemspec Europe 2026: Taros Chemicals at Europe’s Leading Fine and Speciality Chemicals Exhibition Taros Chemicals will attend Chemspec Europe 2026, one of Europe’s key trade fairs for the fine and
Drug Discovery Chemistry 2026: Taros Chemicals to Attend Leading Medicinal Chemistry Conference Taros Chemicals will attend Drug Discovery Chemistry 2026, a major international conference dedicated to medicinal chemistry, small-molecule drug
BioSpring Europe 2026: Taros Chemicals to Participate in Leading Life Science Partnering Event Taros Chemicals will participate in BIO-Europe Spring 2026, one of Europe’s leading partnering conferences for the biotechnology,
At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:
Biotechs simply concentrate on their research and development tasks while our experienced chemists take care of all related synthetic chemistry challenges.
From new release mechanisms in band-aid material to the development of chemistry for innovative dual modes of action to help make use of new imaging techniques (PET).
Innovative display technologies require performance chemicals that allow tomorrow’s visual applications in handheld devices, car interfaces or further intelligent equipment.
Providing innovative but cost efficient early drug discovery services and technologies to our pharma customers is what drives our multidisciplinary scientists at Taros.
From literature research to pilot plant – we deliver sophisticated chemicals with full IP to our customers to help them achieve their product development goals.
Your R&D has a specific idea about how the surface should perform by modulating the coating or the curing? Get in touch with our scientists to discuss your chemistry challenge.
Great academic research often requires industrial backing and excellent synthesis capacities to bring ideas to the market – for many years we have been closing that gap.
Get in touch with us if you’d like to discuss the development of new or the improvement of existing synthetic molecules for fragrances, skin care applications or aroma molecules.
Smarter consumer goods require both improved properties and chemicals that provide an acceptable ecological footprint during their entire life cycle.
